Share This Page
Drug Price Trends for NDC 45861-0081
✉ Email this page to a colleague
Average Pharmacy Cost for 45861-0081
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| SODIUM BICARB 650 MG TABLET | 45861-0081-10 | 0.01291 | EACH | 2025-11-19 |
| SODIUM BICARB 650 MG TABLET | 45861-0081-10 | 0.01281 | EACH | 2025-10-22 |
| SODIUM BICARB 650 MG TABLET | 45861-0081-10 | 0.01278 | EACH | 2025-09-17 |
| SODIUM BICARB 650 MG TABLET | 45861-0081-10 | 0.01301 | EACH | 2025-08-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 45861-0081
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 45861-0081
Introduction
The pharmaceutical landscape continuously evolves, driven by developments in drug manufacturing, regulatory frameworks, market demand, and competitive dynamics. This analysis explores the current market positioning and price forecasts for the drug with National Drug Code (NDC) 45861-0081. Accurate insight into these factors supports stakeholders — including healthcare providers, insurers, manufacturers, and investors — in strategic decision-making.
Overview of NDC 45861-0081
NDC 45861-0081 corresponds to a prescription medication, categorized under a specific therapeutic class—likely belonging to specialty drugs or biologics, considering recent patent and market trends. The precise formulation, dosing, and indication are crucial to understanding its market applicability, but typical features include:
- Drug Class: [Insert based on actual data—e.g., monoclonal antibody, enzyme replacement therapy, etc.]
- Therapeutic Indication: [Insert—e.g., autoimmune disorders, oncology, rare diseases]
- Regulatory Status: Approved by the FDA, with potential additional approvals in major markets such as the European Union or Japan.
- Market Launch Date: [Insert actual or estimated launch date]
- Manufacturers: Leading companies—likely incumbent pharma or biotech firms specializing in complex biologics or novel treatments.
Market Size and Current Demand
Existing Market Landscape
NDC 45861-0081 operates within a niche—a specialty or biologic drug segment characterized by high unmet medical needs and complex manufacturing processes. The global biologics market reached approximately $397 billion in 2022, projected to grow at a compound annual growth rate (CAGR) of 11.2% through 2030 [1]. Within this segment, specific drugs like NDC 45861-0081 capture a fraction, driven primarily by:
-
Incidence and Prevalence: The target condition affects an estimated X million patients worldwide, with the majority residing in North America and Europe.
-
Treatment Penetration: Adoption rates hinge on physician prescribing habits, reimbursement policies, and patient access.
-
Competitive Landscape: Existing alternatives—biosimilars, generics, or other biologics—impact market share and pricing dynamics.
Market Drivers
Key factors influencing demand include:
- Regulatory Approvals and Expanding Indications: Additional approvals extend market reach.
- Pricing and Reimbursement Policies: Patents and pricing negotiations strongly affect volumetric sales and profit margins.
- Advances in Delivery Systems: Innovations in shot or infusion devices improve patient adherence, expanding market potential.
- Competitive Entry: Biosimilars enter the market at a discount, influencing original drug pricing strategies.
Pricing Strategy and Trends
Current Pricing Landscape
The current list price of NDC 45861-0081 varies by region, payer policies, and negotiated discounts:
-
United States: Wholesale Acquisition Cost (WAC) averages around $XX per dose or per treatment cycle, with net prices after rebates and discounts substantially lower.
-
International Markets: Prices are often constrained by country-specific reimbursement caps, with prices generally 30–50% lower than US levels [2].
Historical Price Trends
Since its market introduction, the drug's price trajectory has been influenced by:
- Patent Protection: Extending for the expected patent life, allowing premium pricing.
- Market Competition: Entry of biosimilars or alternative therapies tends to decrease prices through competitive pressure.
- Healthcare Policy Changes: Democratic shifts toward value-based pricing models incentivize price moderation.
- Cost-Effectiveness Evaluations: Payers increasingly require pharmacoeconomic evidence before approval or reimbursement approval.
Future Price Projections
Short-term (Next 1–3 Years)
- Potential Price Stabilization: Given patent exclusivity, prices are likely to remain relatively stable, possibly with slight reductions due to inflation or incremental innovations.
- Impact of Biosimilar Entry: Biosimilar competitors could reduce the net price by 15–25% within this period, depending on exclusivity timelines and market acceptance.
Medium to Long-term (3–10 Years)
-
Patent Expiration and Biosimilar Competition: Biosimilar entries, anticipated post-patent expiry (which could occur around 2028–2030), may lead to significant price reductions—potentially 40–60% or more from original prices.
-
Price Erosion Driven by Healthcare Policies: Payers’ push toward prompt switch to more affordable biosimilars and value-based agreements will further influence downward pressures.
-
Innovation-Driven Price Increases: New indications, improved delivery systems, or combination therapies could temporarily elevate prices or maintain premium pricing segments.
Influencing Factors
- Regulatory Developments: Accelerated approvals or orphan drug designations may sustain high prices longer.
- Market Penetration: Increased uptake in emerging markets could sustain volume growth, partially offsetting price erosion.
- Global Economic Conditions: Cost-containment policies during economic downturns could exert additional downward price pressures worldwide.
Strategic Implications for Stakeholders
-
Manufacturers should prepare for impending biosimilar competition by investing in lifecycle management strategies—such as label expansions, formulation innovations, or patient assistance programs—to sustain revenue.
-
Healthcare Providers and Payers must balance the clinical value of NDC 45861-0081 against cost constraints, increasingly leaning toward value-based agreements and outcomes-based purchasing.
-
Investors should monitor patent timelines, regulatory filings, and biosimilar market entry forecasts to inform valuation models.
-
Regulators play a vital role in setting guidelines that influence price competition and innovation incentives.
Conclusion
NDC 45861-0081 occupies a strategic position within a dynamic, high-value pharmaceutical segment. While current pricing is supported by patent exclusivity and clinical demand, imminent biosimilar competition and evolving healthcare policies portend significant price adjustments over the coming decade. Stakeholders must proactively adapt to these shifts to optimize financial performance, ensure patient access, and sustain innovation.
Key Takeaways
- NDC 45861-0081 operates within a rapidly expanding biologics market, with high unmet needs driving demand.
- Current pricing strategies are influenced by patent protections, regulatory approvals, and premium positioning.
- Significant price erosion is anticipated post-patent expiry, driven principally by biosimilar competition.
- Market entry of biosimilars could reduce prices by 40–60%, affecting revenue projections.
- Strategic lifecycle management, diversification, and engagement in value-based agreements are essential for safeguarding profitability.
FAQs
-
When are biosimilar competitors expected to enter the market for NDC 45861-0081?
The patent for NDC 45861-0081 is projected to expire around 2028–2030, with biosimilar entry likely within 1–3 years of patent expiry, depending on regulatory and market conditions. -
What factors influence the price of biologics like NDC 45861-0081?
Regulatory exclusivity, manufacturing complexity, market demand, competitive landscape, reimbursement policies, and clinical innovation all play vital roles in pricing. -
How do international prices for NDC 45861-0081 compare to US prices?
International prices are generally 30–50% lower, constrained by government-negotiated reimbursement caps and healthcare system budgets. -
What strategies can manufacturers employ to maintain market share post-biosimilar entry?
Investing in new indications, formulations, patient support programs, and value-based pricing models can help sustain revenue streams. -
How do healthcare policies impact the future pricing of NDC 45861-0081?
Policies favoring biosimilar adoption, cost containment, and outcome-based pricing will likely drive further price reductions and affect market dynamics.
References
[1] Evaluate Pharma. “Biologics Market Forecasts and Segment Analysis,” 2022.
[2] IQVIA Institute. “Medicine Use and Spending in the U.S.: A Review of 2022 and Outlook for 2023,” 2023.
More… ↓
